Search Page

1

Cite

Share

IL-5 pathway inhibition in the treatment of asthma and Churg-Strauss syndrome.

Rosenwasser LJ, Rothenberg ME. Rosenwasser LJ, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2010 Jun;125(6):1245-6. doi: 10.1016/j.jaci.2010.04.022. J Allergy Clin Immunol. 2010. PMID: 20513522 No abstract available.

Cite

Share

2

Cite

Share

Chemokines in asthma: cooperative interaction between chemokines and IL-13.

Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Zimmermann N, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2003 Feb;111(2):227-42; quiz 243. doi: 10.1067/mai.2003.139. J Allergy Clin Immunol. 2003. PMID: 12589338 Review.

Cite

Share

3

Cite

Share

Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity.

Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, Dent LA, Young IG, Matthaei KI, Rothenberg ME, Foster PS. Yang M, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2003 Nov;112(5):935-43. doi: 10.1016/j.jaci.2003.08.010. J Allergy Clin Immunol. 2003. PMID: 14610483

Cite

Share

4

Cite

Share

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME. Garrett JK, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2004 Jan;113(1):115-9. doi: 10.1016/j.jaci.2003.10.049. Epub 2003 Dec 12. J Allergy Clin Immunol. 2004. PMID: 14699394 Clinical Trial.

Cite

Share

5

Cite

Share

Eosinophilic gastrointestinal disorders (EGID).

Rothenberg ME. Rothenberg ME. J Allergy Clin Immunol. 2004 Jan;113(1):11-28; quiz 29. doi: 10.1016/j.jaci.2003.10.047. J Allergy Clin Immunol. 2004. PMID: 14713902 Review.

Cite

Share

6

Cite

Share

Molecular mechanisms of anaphylaxis: lessons from studies with murine models.

Finkelman FD, Rothenberg ME, Brandt EB, Morris SC, Strait RT. Finkelman FD, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2005 Mar;115(3):449-57; quiz 458. doi: 10.1016/j.jaci.2004.12.1125. J Allergy Clin Immunol. 2005. PMID: 15753886 Review.

Cite

Share

7

Cite

Share

Anti-IL-5 and hypereosinophilic syndromes.

Sutton SA, Assa'ad AH, Rothenberg ME. Sutton SA, et al. Among authors: rothenberg me. Clin Immunol. 2005 Apr;115(1):51-60. doi: 10.1016/j.clim.2005.02.006. Clin Immunol. 2005. PMID: 15870021 Review.

Cite

Share

8

Cite

Share

IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.

Létuvé S, Lajoie-Kadoch S, Audusseau S, Rothenberg ME, Fiset PO, Ludwig MS, Hamid Q. Létuvé S, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2006 Mar;117(3):590-6. doi: 10.1016/j.jaci.2005.10.025. Epub 2006 Feb 8. J Allergy Clin Immunol. 2006. PMID: 16522458

Cite

Share

9

Cite

Share

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.

Klion AD, Bochner BS, Gleich GJ, Nutman TB, Rothenberg ME, Simon HU, Wechsler ME, Weller PF; The Hypereosinophilic Syndromes Working Group. Klion AD, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2006 Jun;117(6):1292-302. doi: 10.1016/j.jaci.2006.02.042. Epub 2006 May 3. J Allergy Clin Immunol. 2006. PMID: 16750989

Cite

Share

10

Cite

Share

Eosinophilic esophagitis: pathogenesis, genetics, and therapy.

Blanchard C, Wang N, Rothenberg ME. Blanchard C, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2006 Nov;118(5):1054-9. doi: 10.1016/j.jaci.2006.07.038. Epub 2006 Sep 18. J Allergy Clin Immunol. 2006. PMID: 17088129 Review.

Cite

Share